Philips unveils HeartStart Intrepid with IntelliSpace Connect across Europe and select markets worldwide
August 19 2019 - 4:00AM
August 19, 2019
Enhanced communication and seamless data sharing capabilities
augment clinical and operational efficiencies for patient
assessment across emergency care settings
Amsterdam, the Netherlands – Royal Philips
(NYSE: PHG, AEX: PHIA), a global leader in health technology, today
announced the launch of the HeartStart Intrepid
monitor/defibrillator with IntelliSpace Connect. Created to provide
clinical and operational efficiencies at every stage of the
emergency care continuum, the solution lets caregivers evaluate and
treat patients during the most demanding medical emergencies in
both pre-hospital and hospital settings. The Philips HeartStart
Intrepid monitor/defibrillator has received CE Mark approval and is
available for sale in Europe and other select markets in Asia and
Africa [1].
“First responders don’t often know what to expect when they
arrive at the scene of an emergency, so they have to be equipped
and ready to handle anything that may come up in the field,” said
Arman Voskerchyan, Business Leader, Therapeutic Care at Philips. “A
full range of monitoring capabilities and decision support tools
let emergency staff quickly evaluate and treat patients in
life-threatening situations. Enhanced connectivity between care
settings helps to streamline communication and improve clinical
workflow for caregivers, ultimately allowing them to provide
patients with better care.”
The HeartStart Intrepid monitor/defibrillator can also be used
across various emergency settings in the hospital, allowing
clinicians to assess the patient and deliver the appropriate
treatment, including defibrillation if a patient is suffering a
sudden cardiac arrest. The cloud-based IntelliSpace Connect data
management solution helps set the stage for coordinated care across
the patient’s clinical care journey. IntelliSpace Connect supports
the integration of emergency event data into electronic patient
care reporting (ePCR) and electronic medical records (EMR/EHR) for
accurate event documentation to facilitate billing, while secure
data storage enables post-event review to drive quality improvement
initiatives.
Designed to be lightweight, portable and rugged, the Philips
HeartStart Intrepid can endure both the rigors of emergency medical
service (EMS) use and the physical demands of the Emergency
Department, as well intra-hospital transport. It offers
comprehensive vital patient monitoring parameters and diagnostic
measurements to speed triage and help clinicians determine the best
course of care. To assist in the delivery of quality CPR, the
Intrepid also offers the QCPR solution which provides integrated
CPR feedback and guidance for both compressions and ventilations.
In addition, with the HeartStart Intrepid, Philips
introduces the Traumatic Brain Injury (TBI) Advisory, a unique
feature based on key patient vital sign assessment to provide
visual guidance to help prevent serious complications in patients
with suspected TBI. IntelliSpace Connect can be accessed through a
browser eliminating the need for specialized hardware and software
upgrades. Powered by Philips HealthSuite, a secure and reliable
cloud platform, IntelliSpace Connect provides a simple,
cost-effective option for hospitals through a Software-as-a-Service
model [2].
For information on how the solution can improve clinical
workflow, simplify record keeping and enhance patient care, while
also streamlining communication and collaboration, visit
www.philips.com/intrepid.
[1] The HeartStart Intrepid with IntelliSpace Connect is not
available for sale in North America.[2] Not all features are
available in all geographies.
For further information, please contact:
Kathy O’ReillyPhilips Group Press OfficeTel:
+1-978-221-8919Email: kathy.oreilly@philips.comTwitter:
@kathyoreilly
Joost MalthaPhilips Group Press OfficeTel: +31 6 10 55
8116Email: joost.maltha@philips.comTwitter:
@joostmalthaAbout Royal
PhilipsRoyal Philips (NYSE: PHG, AEX: PHIA) is a
leading health technology company focused on improving people's
health and enabling better outcomes across the health continuum
from healthy living and prevention, to diagnosis, treatment and
home care. Philips leverages advanced technology and deep clinical
and consumer insights to deliver integrated solutions.
Headquartered in the Netherlands, the company is a leader in
diagnostic imaging, image-guided therapy, patient monitoring and
health informatics, as well as in consumer health and home care.
Philips generated 2018 sales of EUR 18.1 billion and employs
approximately 78,000 employees with sales and services in more than
100 countries. News about Philips can be found
at www.philips.com/newscenter.
- HeartStart Intrepid v1
- HeartStart Intrepid
Koninklijke Philips NV (NYSE:PHG)
Historical Stock Chart
From Mar 2024 to Apr 2024
Koninklijke Philips NV (NYSE:PHG)
Historical Stock Chart
From Apr 2023 to Apr 2024